Download PDF
Neuropediatrics 2016; 47(01): 020-023
DOI: 10.1055/s-0035-1566232
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Role and Clinical Significance of Plasma N-Terminal Brain Natriuretic Peptide Measurement in Children with Brain Edema

Mustafa Taskesen
1   Department of Pediatrics, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
,
Hasan Celik
1   Department of Pediatrics, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
,
Ahmet Yaramis
2   Department of Pediatric Neurology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
,
Mehmet A. Tas
1   Department of Pediatrics, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
› Author Affiliations
Further Information

Publication History

09 April 2015

09 September 2015

Publication Date:
16 November 2015 (online)

Also available at
    Permissions and Reprints

Abstract

Objective Brain natriuretic peptide (BNP) is a potent natriuretic and vasodilator factor. BNP plasma concentrations were found to be elevated in patients with brain edema. The purpose of the present study is to evaluate the relationship between plasma NT-proBNP concentration and the presence of brain edema in patients with intracranial pathology.

Materials and Methods The plasma NT-proBNP levels of 50 patients and 25 healthy subjects were measured. The NT-proBNP levels of the patient group were measured during admission and after 7 days of treatment.

Results NT-proBNP plasma concentrations were found to be significantly higher in the patient group with brain edema than in the control group (p < 0.005). There were no significant differences in the NT-proBNP plasma concentrations between patients with intracranial pathology without brain edema and the control group (p > 0.005). NT-proBNP plasma concentrations were found to be significantly higher in patients with brain edema as compared with patients without brain edema before treatment (p < 0.005).

Conclusion These results suggest that excessive secretion of plasma NT-proBNP is related to brain edema. Plasma NT-proBNP levels may serve as a marker to guide the early-diagnostic and therapeutic management in children with brain edema. Further studies are required to evaluate the role of BNP in brain edema pathophysiology.

Keywords

brain edema - NT-proBNP - children
 

  • References

  • 1 Tasker RC, Acerini CL. Cerebral edema in children with diabetic ketoacidosis: vasogenic rather than cellular?. Pediatr Diabetes 2014; 15 (4) 261-270
    CrossrefPubMedGoogle Scholar
  • 2 Qureshi AI, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 2000; 28 (9) 3301-3313
    CrossrefPubMedGoogle Scholar
  • 3 Bingaman WE, Frank JI. Malignant cerebral edema and intracranial hypertension. Neurol Clin 1995; 13 (3) 479-509
    PubMedGoogle Scholar
  • 4 Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332 (6159) 78-81
    CrossrefPubMedGoogle Scholar
  • 5 Saper CB, Hurley KM, Moga MM , et al. Brain natriuretic peptides: differential localization of a new family of neuropeptides. Neurosci Lett 1989; 96 (1) 29-34
    CrossrefPubMedGoogle Scholar
  • 6 Hodes A, Lichtstein D. Natriuretic hormones in brain function. Front Endocrinol (Lausanne) 2014; 5: 201
    PubMedGoogle Scholar
  • 7 Abdelalim EM, Takada T, Torii R, Tooyama I. Molecular cloning of BNP from heart and its immunohistochemical localization in the hypothalamus of monkey. Peptides 2006; 27 (7) 1886-1893
    CrossrefPubMedGoogle Scholar
  • 8 McKenzie JC, Berman NE, Thomas CR , et al. Atrial natriuretic peptide-like (ANP-LIR) and ANP prohormone immunoreactive astrocytes and neurons of human cerebral cortex. Glia 1994; 12 (3) 228-243
    CrossrefPubMedGoogle Scholar
  • 9 Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003; 24 (3) 341-356
    CrossrefPubMedGoogle Scholar
  • 10 Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339 (5) 321-328
    CrossrefPubMedGoogle Scholar
  • 11 Kanğın M, Pirinççioğlu AG, Aylan Ö. Plasma Natriuretic Peptides As Predictors of Hemodynamically in Children with Congenital Heart Disease. International Archives of Medical Research 2012; 4 (2) 8-14
    PubMedGoogle Scholar
  • 12 James ML, Wang H, Venkatraman T, Song P, Lascola CD, Laskowitz DT. Brain natriuretic peptide improves long-term functional recovery after acute CNS injury in mice. J Neurotrauma 2010; 27 (1) 217-228
    CrossrefPubMedGoogle Scholar
  • 13 Kirchhoff C, Stegmaier J, Bogner V , et al. Intrathecal and systemic concentration of NT-proBNP in patients with severe traumatic brain injury. J Neurotrauma 2006; 23 (6) 943-949
    CrossrefPubMedGoogle Scholar
  • 14 Powner DJ, Hergenroeder GW, Awili M, Atik MA, Robertson C. Hyponatremia and comparison of NT-pro-BNP concentrations in blood samples from jugular bulb and arterial sites after traumatic brain injury in adults: a pilot study. Neurocrit Care 2007; 7 (2) 119-123
    CrossrefPubMedGoogle Scholar
  • 15 Koenig MA, Puttgen HA, Prabhakaran V, Reich D, Stevens RD. B-type natriuretic peptide as a marker for heart failure in patients with acute stroke. Intensive Care Med 2007; 33 (9) 1587-1593
    CrossrefPubMedGoogle Scholar
  • 16 McGirt MJ, Blessing R, Nimjee SM , et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 2004; 54 (6) 1369-1373 , discussion 1373–1374
    CrossrefPubMedGoogle Scholar
  • 17 James ML, Blessing R, Phillips-Bute BG, Bennett E, Laskowitz DT. S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage. Biomarkers 2009; 14 (6) 388-394
    CrossrefPubMedGoogle Scholar
  • 18 Sviri GE, Feinsod M, Soustiel JF. Brain natriuretic peptide and cerebral vasospasm in subarachnoid hemorrhage. Clinical and TCD correlations. Stroke 2000; 31 (1) 118-122
    CrossrefPubMedGoogle Scholar
  • 19 Nakagawa K, Yamaguchi T, Seida M , et al. Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis 2005; 19 (3) 157-164
    CrossrefPubMedGoogle Scholar
  • 20 Iltumur K, Yavavli A, Apak I, Ariturk Z, Toprak N. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke. Am Heart J 2006; 151 (5) 1115-1122
    CrossrefPubMedGoogle Scholar
  • 21 Sviri GE, Soustiel JF, Zaaroor M. Alteration in brain natriuretic peptide (BNP) plasma concentration following severe traumatic brain injury. Acta Neurochir (Wien) 2006; 148 (5) 529-533 , discussion 533
    CrossrefPubMedGoogle Scholar
  • 22 Berendes E, Walter M, Cullen P , et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 1997; 349 (9047) 245-249
    CrossrefPubMedGoogle Scholar
  • 23 Çevik Y, Durukan P, Erol FS, Yıldız M, Ilhan N, Serhatlioglu S. Diagnostic Value of Bedside Brain Natriuretic Peptide Measurement in Patients with Head Trauma. JAEM 2010; 9: 21-25
    PubMedGoogle Scholar
  • 24 Fukui S, Katoh H, Tsuzuki N , et al. Focal brain edema and natriuretic peptides in patients with subarachnoid hemorrhage. J Clin Neurosci 2004; 11 (5) 507-511
    CrossrefPubMedGoogle Scholar